Click me
Transcribed

transvaginal mesh

Transvaginal Mesh Patch It's Purpose: Transvaginal Mesh Patch was designed to permanently treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). These conditions are caused when a woman's pelvic muscles are weakened and stretched during childbirth and some other instances. The transvaginal mesh patch is a synthetic mesh that is implanted transvaginally (through the vagina) to provide support for the abdominal organs. Serious Side Effects: Erosion and exposure of mesh Recto vaginal fistula Recurrence of POP and SUI Common Side Effects: Urinary problems Irregular bleeding Pain during intercourse Chronic pain and infection 1996 The FDA approves Boston Scientific to manufacture and market first transvaginal mesh patch, Protegen, under its 501(k) approval process. 1998 2/3 Of All Complaints 1999 FDA inspection reveals that nearly 2/3 of all complaints against Boston Scientific are for transvaginal mesh products. Boston Scientific recalls Protegen stating the device "does not produce outcomes that are consistent with the company's standard of performance for its products or customer expectations." The recall was issued after the company received complaints about pain during intercourse and erosion of vaginal tissue. 2003 738 Lawsuits Boston Scientific settles 738 transvaginal mesh patch lawsuits for an undisclosed amount. 2007 The FDA receives more than 1,000 reports that transvaginal mesh products from various manufacturers cause pain, infection, urinary problems, erosion of vaginal tissue, and recurrence of POP and SUI. 1,000 Reports 2008 The FDA issues a warning about transvaginal mesh products but only states that adverse side effects are rare but potentially serious. 2010 2011 The FDA receives an additional 2,874 10% of Women reports of adverse side effects caused by transvaginal mesh. It also received 7 reports that the device caused death. Additionally, the FDA estimates that almost 300,000 women have received An FDA advisory panel recommends that transvaginal mesh products be classified as high-risk, therefore transvaginal mesh patch products. requiring manufacturers studies based on human testing. The EDA also examined data from 110 conduct 7 Deaths studies including 11,785 women, and determined that approximately 10 percent of women undergoing 11.785 2012 transvaginal POP repair with mesh experienced mesh erosion within 12 months of surgery. The FDA orders 35 transvaginal mesh manufacturers to conduct studies on the complications associated with transvaginal mesh products. As result, C.R. Bard stopped marketing transvaginal mesh products in the United States. 2013 18 Surgeries a its Reports indicate that more than 8,000 transvaginal mesh claims have filed and the first transvaginal mesh trial begins. The plaintiff alleges that she underwent 18 surgeries to correct the injuries caused by Johnson & Johnson's transvaginal mesh product. 1 Woman Federal claims are consolidated through multidistrict litigation and are centralized before the United States District Court for the Southern District of West Virginia. Do You Have A Transvaginal Mesh Patch Claim? If you or a loved one has been injured by the transvaginal mesh device, you may want to speak with a personal injury attorney regarding a potential claim. A lawyer familiar with new developments in the investigation of transvaginal mesh may be able to help you make important personal and legal decisions. d'Oliveira & Associates is working with some of the leading medical device lawyers in the country who are handling these cases. Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 Transvaginal Mesh Patch It's Purpose: Transvaginal Mesh Patch was designed to permanently treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). These conditions are caused when a woman's pelvic muscles are weakened and stretched during childbirth and some other instances. The transvaginal mesh patch is a synthetic mesh that is implanted transvaginally (through the vagina) to provide support for the abdominal organs. Serious Side Effects: Erosion and exposure of mesh Recto vaginal fistula Recurrence of POP and SUI Common Side Effects: Urinary problems Irregular bleeding Pain during intercourse Chronic pain and infection 1996 The FDA approves Boston Scientific to manufacture and market first transvaginal mesh patch, Protegen, under its 501(k) approval process. 1998 2/3 Of All Complaints 1999 FDA inspection reveals that nearly 2/3 of all complaints against Boston Scientific are for transvaginal mesh products. Boston Scientific recalls Protegen stating the device "does not produce outcomes that are consistent with the company's standard of performance for its products or customer expectations." The recall was issued after the company received complaints about pain during intercourse and erosion of vaginal tissue. 2003 738 Lawsuits Boston Scientific settles 738 transvaginal mesh patch lawsuits for an undisclosed amount. 2007 The FDA receives more than 1,000 reports that transvaginal mesh products from various manufacturers cause pain, infection, urinary problems, erosion of vaginal tissue, and recurrence of POP and SUI. 1,000 Reports 2008 The FDA issues a warning about transvaginal mesh products but only states that adverse side effects are rare but potentially serious. 2010 2011 The FDA receives an additional 2,874 10% of Women reports of adverse side effects caused by transvaginal mesh. It also received 7 reports that the device caused death. Additionally, the FDA estimates that almost 300,000 women have received An FDA advisory panel recommends that transvaginal mesh products be classified as high-risk, therefore transvaginal mesh patch products. requiring manufacturers studies based on human testing. The EDA also examined data from 110 conduct 7 Deaths studies including 11,785 women, and determined that approximately 10 percent of women undergoing 11.785 2012 transvaginal POP repair with mesh experienced mesh erosion within 12 months of surgery. The FDA orders 35 transvaginal mesh manufacturers to conduct studies on the complications associated with transvaginal mesh products. As result, C.R. Bard stopped marketing transvaginal mesh products in the United States. 2013 18 Surgeries a its Reports indicate that more than 8,000 transvaginal mesh claims have filed and the first transvaginal mesh trial begins. The plaintiff alleges that she underwent 18 surgeries to correct the injuries caused by Johnson & Johnson's transvaginal mesh product. 1 Woman Federal claims are consolidated through multidistrict litigation and are centralized before the United States District Court for the Southern District of West Virginia. Do You Have A Transvaginal Mesh Patch Claim? If you or a loved one has been injured by the transvaginal mesh device, you may want to speak with a personal injury attorney regarding a potential claim. A lawyer familiar with new developments in the investigation of transvaginal mesh may be able to help you make important personal and legal decisions. d'Oliveira & Associates is working with some of the leading medical device lawyers in the country who are handling these cases. Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878

transvaginal mesh

shared by dmlaw on Feb 17
240 views
0 shares
0 comments
Transvaginal Mesh Devices have been linked to severe complications including infection, scarring, and perforation of internal organs. We are working with some of the leading Transvaginal Mesh Patch at...

Category

Health
Did you work on this visual? Claim credit!

Get a Quote

Embed Code

For hosted site:

Click the code to copy

For wordpress.com:

Click the code to copy
Customize size